The CAA actually does mention viral causes and they are (or just were) currently funding research into a viral cause of CFS - those endogenous retroviruses. Dr. Vernon actually told me that when she first came to the CAA that she thought the research program would be ALL viral; thats' what she wanted to do. As it turned out one study looks at the micro-organisms in the gut -a pathogen study and then there is (or was) the HERV study and the rest are looking at other physiological factors.
Over the years the CAA has funded alot of research into pathogens - more than anyone else.
I agree that they don't push the viral angle much. It was really out of favor for quite a while in the research world. Over the past 3 or 4 years with Dr. Chia's, Dr. Montoya's (which didn't really work out yet), Dr. Lerner's and the WPI's work has pushed it more into the forefront.
What the CAA does not really do, I don't think, is talk much about antiviral treatments. I could be wrong but my sense is they're very conservative in that area. These are some of the few treatments that have the possibility, I think, of returning very ill patients to health. They tend to be quite expensive and, of course, there are the possibility of side effects. Nevertheless they are an important part of the treatment picture. I don't that the CAA has gotten on top of those.
They do seem to prefer more innocuous subjects like 'pacing'
There is a conversatism, I think, in the treatment area, that gets tiring. I just did a blog on a patients significant recovery using Vistide; its a tough, tough drug - its off-label. its not approved for CFS, it can wipe out your kidneys in ONE treatment, its VERY expensive...but it did work with this person. Would the CAA do that article? I don't know if they would
Their research program is very bold, very innovative...in other areas I think patients would love to see them branch out more.